89 related articles for article (PubMed ID: 6858561)
1. Tumorigenicity and immunogenicity of somatic cell hybrids between L1210 mouse leukemia cell and L-fibroblast.
Watanabe E; Kawashima K; Isobe K; Yamada K; Saga S; Takahashi T
Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):121-9. PubMed ID: 6858561
[No Abstract] [Full Text] [Related]
2. Production of anti-self-h-2 antibodies by C3D2F1 mice hyperimmune to L cell/L1210 hybrids and L1210 leukemia cells.
Kawashima K; Watanabe E; Isobe K; Ogura M; Nagura E; Yamada K; Sobue I; Mizoguchi K; Ito Y; Nagai Y; Nakashima I
Cell Immunol; 1982 Mar; 67(2):279-86. PubMed ID: 7083334
[No Abstract] [Full Text] [Related]
3. Tumor-specific immunity induced by somatic hybrids. I. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids.
Kim BS; Liang W; Cohen EP
J Immunol; 1979 Aug; 123(2):733-8. PubMed ID: 88482
[TBL] [Abstract][Full Text] [Related]
4. [Expression of malignancy traits in the interspecific somatic hybrids of tumor and normal cells].
Kakpakova ES
Genetika; 1983 Nov; 19(11):1845-50. PubMed ID: 6317520
[TBL] [Abstract][Full Text] [Related]
5. Expression of tumor-specific antigens in mouse somatic cell hybrids.
Jami J; Ritz E
Cancer Res; 1973 Oct; 33(10):2524-8. PubMed ID: 4355034
[No Abstract] [Full Text] [Related]
6. Immunostimulatory factors specifically associated with a spontaneously regressing tumor subline of the murine leukemia L1210.
Koo PH
J Immunol; 1981 Jul; 127(1):373-9. PubMed ID: 7016996
[No Abstract] [Full Text] [Related]
7. Tumorigenicity of intraspecific somatic cell hybrids in nude mice.
Aden DP; Knowles BB
J Natl Cancer Inst; 1977 Mar; 58(3):743-6. PubMed ID: 839566
[TBL] [Abstract][Full Text] [Related]
8. Nonmalignancy of hybrids derived from two mouse malignant cells. I. Hybrids between L1210 leukemia cells and malignant L cells.
Jami J; Ritz E
J Natl Cancer Inst; 1973 Nov; 51(5):1647-53. PubMed ID: 4762938
[No Abstract] [Full Text] [Related]
9. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
Fuji H
Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
[TBL] [Abstract][Full Text] [Related]
10. [A new technic for determining the number of clonogenic L1210 cells].
Chevalier C; Frindel E
Bull Cancer; 1972; 59(3):339-44. PubMed ID: 4667743
[No Abstract] [Full Text] [Related]
11. Serologically defined antigens on the surface of somatic hybrid cells.
Rubio N
Int Arch Allergy Appl Immunol; 1982; 67(2):123-6. PubMed ID: 7056591
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
[TBL] [Abstract][Full Text] [Related]
13. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
Fuji H; Murakami M
J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
[TBL] [Abstract][Full Text] [Related]
14. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
[TBL] [Abstract][Full Text] [Related]
15. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
Fuji H; Mihich E
Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of cell membranes from somatic cell hybrids between rat hepatoma and mouse L-cells.
Marciani DJ; Lyons LB; Thompson EB
Cancer Res; 1976 Aug; 36(8):2937-44. PubMed ID: 179711
[TBL] [Abstract][Full Text] [Related]
17. Characterization of "H-2K,D-like structures" on MM2 x mouse L cell hybrids. II. An "H-2Kd-like" structure on C3H-derived tumor.
Kubota K; Manson LA
Int J Cancer; 1983 May; 31(5):655-60. PubMed ID: 6852981
[TBL] [Abstract][Full Text] [Related]
18. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
19. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
[TBL] [Abstract][Full Text] [Related]
20. Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.
Fuji H; Iribe H
Cancer Res; 1986 Nov; 46(11):5541-7. PubMed ID: 3489524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
